---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-041852"
form_type: "8-K"
ticker: "BCAB"
cik: "0001826892"
company_name: "BioAtla, Inc."
filed_at: "2026-02-09T23:59:59+00:00"
generated_at: "2026-05-16T03:56:04.193828+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Nasdaq Listing Council stays BCAB delisting, calls review of Feb 6 non-compliance determination

## Summary
- Nasdaq determined Feb 6 to delist BCAB for non-compliance with bid price ($1) and stockholders' equity ($2.5M) requirements.
- On Feb 8, Nasdaq Listing Council called review of delist decision and stayed suspension; BCAB continues trading on Nasdaq.
- Company asserts Nasdaq's delay and policy change on super-voting stock caused irreparable harm.
- Listing Council review may take weeks to months; no assurance stock will remain listed after review.

## SEC filing metadata
- accession: 0001193125-26-041852
- form_type: 8-K
- ticker: BCAB
- cik: 0001826892
- company_name: BioAtla, Inc.
- filed_at: 2026-02-09T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826892/000119312526041852/0001193125-26-041852-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826892/000119312526041852/d317360d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-041852
- JSON: https://secwatch.observer/filing/0001193125-26-041852.json
- Plain text: https://secwatch.observer/filing/0001193125-26-041852.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.